Background Antipsychotic treatment is associated with metabolic disturbance. However, the
degree to which metabolic alterations occur in treatment with different antipsychotics is …

Importance Schizophrenia is a common, severe mental illness that most clinicians will
encounter regularly during their practice. This report provides an overview of the clinical …

The mesolimbic hypothesis has been a central dogma of schizophrenia for decades,
positing that aberrant functioning of midbrain dopamine projections to limbic regions causes …

Glutamate and dopamine systems play distinct roles in terms of neuronal signalling, yet both
have been proposed to contribute significantly to the pathophysiology of schizophrenia. In …

The 22q11.2 deletion syndrome (22q11.2DS) is a neurodevelopmental disorder associated
with a number of volumetric brain abnormalities. The syndrome is also associated with an …

Cognitive deficits are a core feature of schizophrenia, account for much of the impaired
functioning associated with the disorder and are not responsive to existing treatments. In this …

Immune parameters are elevated in psychosis, but it is unclear whether alterations are
homogenous across patients or heterogeneity exists, consistent with the hypothesis that immune …

A recent “umbrella” review examined various biomarkers relating to the serotonin system, and
concluded there was no consistent evidence implicating serotonin in the pathophysiology …

Converging lines of evidence suggest that glutamatergic dysfunction may contribute to the
pathophysiology of first episode psychosis. We investigated whether first episode psychosis …

Background Cardiovascular disease is a major cause of excess mortality in people with
schizophrenia. Several factors are responsible, including lifestyle and metabolic effects of …